Welcome to our dedicated page for Hca Healthcare news (Ticker: HCA), a resource for investors and traders seeking the latest updates and insights on Hca Healthcare stock.
HCA Healthcare operates a healthcare services network built around acute-care hospitals and ambulatory sites of care in the United States and the United Kingdom. Company news commonly addresses hospital operating trends, same-facility admissions, emergency room visits, inpatient and outpatient surgeries, revenue per equivalent admission and quarterly financial results.
Updates also cover capital allocation and financing activity, including dividends, share repurchase authorizations, commercial paper, senior notes issued by HCA Inc., and debt redemptions. Other recurring developments include hospital quality recognition, investor conference presentations, enterprise marketing and corporate affairs leadership, and the role of surgery centers, freestanding ERs, urgent care centers and physician clinics within HCA's ambulatory care platform.
HCA Healthcare, one of the leading healthcare providers in the U.S., released its annual Impact Report detailing significant contributions to patient care and community support in 2022. The report highlights over 37 million patient encounters and high safety ratings, with over 80% of HCA hospitals receiving an 'A' or 'B' safety grade. The company invested approximately $3.5 billion in charity care and formed a Patient Advisory Group to enhance care equity. Notably, HCA Healthcare hired over 123,000 colleagues and supported diverse initiatives, including $44 million in community donations. The report underscores HCA's commitment to improving healthcare outcomes and community well-being.
Summary not available.
HealthTrust Workforce Solutions (HWS) has announced the promotions of Steve Wright to Chief Operations Officer and Jim Davis to Chief Revenue Officer. Wright, with HWS since 2014, has elevated the company’s operational excellence, while Davis has grown the Managed Service Provider (MSP) business significantly since joining in 2013. Brendan Courtney, President and CEO of HWS, emphasized the company’s above-market growth over the last decade, even amidst healthcare industry challenges. HWS, part of HCA Healthcare, aims to enhance patient care and operational performance through a range of staffing and educational services.
HCA Healthcare, a leading healthcare provider, announced a total of over $44 million in donations to community organizations for 2022, surpassing the $41 million given in 2021. Contributions focused on disaster relief, health equity, and access to healthcare careers. The company also invested in initiatives like a $15 million partnership with the American Heart Association aimed at addressing health disparities. Other notable donations include $1.5 million each to Fisk University and Tennessee State University to support healthcare education. In addition, colleague giving reached nearly $17 million in 2022.
HCA Healthcare (NYSE: HCA) will present at several healthcare conferences in March 2023. The schedule includes:
- March 7 at 10:25 am EST, 44th Annual Institutional Investors Conference, Orlando, FL.
- March 8 at 9:50 am EST, 43rd Annual Health Care Conference, Boston, MA.
- March 14 at 11:20 am EDT, Oppenheimer 33rd Annual Virtual Healthcare Conference.
Webcasts and related presentations will be available on HCA's Investor Relations website. Dates/times may change, so check the website for updates.
HCA Healthcare reported strong financial results for Q4 2022, with revenues of $15.497 billion, up from $15.064 billion in Q4 2021. Net income rose to $2.081 billion or $7.28 per diluted share, compared to $1.814 billion or $5.75 per diluted share in the previous year. Adjusted EBITDA was $3.179 billion, slightly higher than $3.149 billion year-over-year. The company faced $50 million in losses due to Hurricane Ian and reported a decline in same facility revenue per equivalent admission by 2.6%.
For the full year, revenues reached $60.233 billion, while net income fell to $5.643 billion from $6.956 billion.
HCA Healthcare has announced over $300,000 in grants to support educational initiatives through its Healthier Tomorrow Fund. This includes $250,000 for community colleges and universities, and $130,000 to the Urban League of Broward County. Notable grants include $50,000 each to Austin Community College, Metro State University, Miami Dade College, Pensacola State College, and the University of Texas at Arlington. This funding aims to enhance healthcare career pathways for high school students and connect jobseekers to opportunities in the healthcare sector.
HCA Healthcare will host its 4Q Earnings Release Call on January 27, 2023, at 9:00 AM CST (10:00 AM EST). The event will be accessible via a live audio webcast, which can be found on the company’s investor relations website. For those unable to join live, an archived version will be available thereafter. This call will focus on the company's financial performance and future outlook.
HCA Healthcare, a leading healthcare provider, has adopted its Enhanced Surgical Recovery (ESR) program across 167 facilities. This patient-focused approach has resulted in significant improvements, such as a two-day reduction in hospital stays and a 44% decrease in opioid usage for some surgeries. Key tactics include goal-directed fluid therapy and early patient mobilization. With over 2 million patients engaged, HCA has committed $20 million to expand the program, based on positive outcomes like a 54% decrease in 30-day readmissions for joint replacements.
Sarah Cannon Research Institute, in partnership with US Oncology Research and Ontada, is set to present over 65 abstracts at the American Society of Hematology (ASH) Annual Meeting from Dec. 10-13. This collaboration, formed in November 2022, enhances patient access to clinical trials across 250 locations in 26 states. More than 40 investigators will showcase advancements in blood cancer treatments, including innovative therapies like CAR T-Cell Therapy. Key presentations include significant studies on sickle cell disease and advanced Hodgkin lymphoma.